Search Results

Filter
  • 1-10 of  2,122 results for ""Oseltamivir""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system.

  • Authors : Li Y; Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.; Wang X

Subjects: Dibenzothiepins*/Dibenzothiepins*/Dibenzothiepins*/adverse effects ; Triazines*/Triazines*/Triazines*/adverse effects ; Oseltamivir*/Oseltamivir*/Oseltamivir*/adverse effects

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 May 09; Vol. 24 (1), pp. 446. Date of Electronic Publication: 2024 May 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

×
Editorial & Opinion

Oseltamivir for All: Should It Become an Over-the-Counter Medication for Influenza Treatment?

  • Authors : Rech MA; Department of Emergency Medicine, Department of Pharmacy, Stritch School of Medicine, Loyola University Chicago, Loyola University Medical Center, Maywood, Illinois.

Subjects: Nonprescription Drugs*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Influenza, Human/Influenza, Human/Influenza, Human/*drug therapy

  • Source: Pharmacotherapy [Pharmacotherapy] 2020 Mar; Vol. 40 (3), pp. 182-185. Date of Electronic Publication: 2020 Feb 12.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

The Impact of Immunization and Use of Oseltamivir on Influenza-Related Hospitalizations: A Population-Based Study.

Subjects: Vaccination*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hospitalization/Hospitalization/Hospitalization/*statistics & numerical data

  • Source: Journal of primary care & community health [J Prim Care Community Health] 2021 Jan-Dec; Vol. 12, pp. 21501327211005906.Publisher: Sage Publications Country of Publication: United States NLM ID: 101518419 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Patterns of seasonal influenza activity in U.S. core-based statistical areas, described using prescriptions of oseltamivir in Medicare claims data.

  • Authors : Dahlgren FS; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, Atlanta, GA, USA. Electronic address: .; Shay DK

Subjects: Medicare* ; Seasons*; Geriatric Assessment/Geriatric Assessment/Geriatric Assessment/*statistics & numerical data

  • Source: Epidemics [Epidemics] 2019 Mar; Vol. 26, pp. 23-31. Date of Electronic Publication: 2018 Aug 29.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101484711 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluating oseltamivir prescriptions in Centers for Medicare and Medicaid Services medical claims records as an indicator of seasonal influenza in the United States.

  • Authors : Dahlgren FS; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, Atlanta, GA, USA.; Shay DK

Subjects: Centers for Medicare and Medicaid Services, U.S.* ; Medical Records*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2018 Jul; Vol. 12 (4), pp. 465-474. Date of Electronic Publication: 2018 Mar 25.Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-2659

Record details

×
Academic Journal

Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies.

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacokinetics ; Influenza, Human/Influenza, Human/Influenza, Human/*drug therapy

  • Source: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2015 Jul; Vol. 53 (7), pp. 531-40.Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Equity in the Receipt of Oseltamivir in the United States During the H1N1 Pandemic.

Subjects: *CLUSTER analysis (Statistics); *STATISTICAL correlation; *INCOMEUNITED States

  • Source: American Journal of Public Health. Jun2014, Vol. 104 Issue 6, p1052-1058. 7p. 4 Charts, 1 Graph.

Record details

×
Academic Journal

Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries.

  • Authors : Mosholder AD; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.; Racoosin JA

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*adverse effects ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*adverse effects ; Hemorrhage/Hemorrhage/Hemorrhage/*chemically induced

  • Source: The Annals of pharmacotherapy [Ann Pharmacother] 2013 Nov; Vol. 47 (11), pp. 1420-8.Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print Cited Medium: Internet

Record details

×
Editorial & Opinion

Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012.

Subjects: Adverse Drug Reaction Reporting Systems* ; United States Food and Drug Administration*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*adverse effects

  • Source: BMJ (Clinical research ed.) [BMJ] 2013 Jul 23; Vol. 347, pp. f4656. Date of Electronic Publication: 2013 Jul 23.Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Safety profile of oseltamivir during the 2009 influenza pandemic.

Subjects: Adverse Drug Reaction Reporting Systems* ; Pandemics*/Pandemics*/Pandemics*/prevention & control ; Pandemics*/Pandemics*/Pandemics*/statistics & numerical data

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2011 May; Vol. 20 (5), pp. 532-43.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic)

Record details

×
  • 1-10 of  2,122 results for ""Oseltamivir""